Luteolin: a blocker of SARS-CoV-2 cell entry based on relaxed complex scheme, molecular dynamics simulation, and metadynamics

Simple item page
dc.contributor.authorShadrack, Daniel M.
dc.contributor.authorDeogratias, Geradius
dc.contributor.authorKiruri, Lucy W.
dc.contributor.authorOnoka, Isaac
dc.contributor.authorVianne, John-Mary
dc.contributor.authorSwai, Hulda
dc.contributor.authorNyandoro, Stephen S.
dc.date.accessioned2023-05-24T08:59:22Z
dc.date.available2023-05-24T08:59:22Z
dc.date.issued2021
dc.descriptionAbstract. Full text available at https://doi.org/10.1007/s00894-021-04833-xen_US
dc.description.abstractNatural products have served human life as medications for centuries. During the outbreak of COVID-19, a number of naturally derived compounds and extracts have been tested or used as potential remedies against COVID-19. Tetradenia riparia extract is one of the plant extracts that have been deployed and claimed to manage and control COVID-19 by some communities in Tanzania and other African countries. The active compounds isolated from T. riparia are known to possess various biological properties including antimalarial and antiviral. However, the underlying mechanism of the active compounds against SARS-CoV-2 remains unknown. Results in the present work have been interpreted from the view point of computational methods including molecular dynamics, free energy methods, and metadynamics to establish the related mechanism of action. Among the constituents of T. riparia studied, luteolin inhibited viral cell entry and was thermodynamically stable. The title compound exhibit residence time and unbinding kinetics of 68.86 ms and 0.014 /ms, respectively. The findings suggest that luteolin could be potent blocker of SARS-CoV-2 cell entry. The study shades lights towards identification of bioactive constituents from T. riparia against COVID-19, and thus bioassay can be carried out to further validate such observations.en_US
dc.identifier.citationShadrack, D. M., Deogratias, G., Kiruri, L. W., Onoka, I., Vianney, J. M., Swai, H., & Nyandoro, S. S. (2021). Luteolin: a blocker of SARS-CoV-2 cell entry based on relaxed complex scheme, molecular dynamics simulation, and metadynamics. Journal of Molecular Modeling, 27, 1-15.en_US
dc.identifier.otherDOI: https://doi.org/10.1007/s00894-021-04833-x
dc.identifier.urihttp://hdl.handle.net/20.500.12661/3913
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.subjectSARS-CoV-2en_US
dc.subjectMetadynamicsen_US
dc.subjectLuteolinen_US
dc.subjectDockingen_US
dc.subjectCOVID-19en_US
dc.subjectTetradenia ripariaen_US
dc.subjectT. ripariaen_US
dc.subjectViral cellsen_US
dc.subjectTanzaniaen_US
dc.subjectAfrican countriesen_US
dc.subjectNatural productsen_US
dc.subjectMolecular dynamics simulationen_US
dc.titleLuteolin: a blocker of SARS-CoV-2 cell entry based on relaxed complex scheme, molecular dynamics simulation, and metadynamicsen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Shadrack-Luteolin-a blocker of SARS-CoV-2 cell entry.pdf
Size:
95.59 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Journal Articles